Search Results
Found 1 results
510(k) Data Aggregation
(32 days)
ACE CARBAMAZEPINE REAGENT/AED CALIBRATORS
ACE® Carbamazepine Reagent is intended for use in the quantitative determination of carbamazepine in human serum.
ACE® Carbamazepine Reagent is intended for the quantitative determination of carbamazepine in serum using the ACE® clinical chemistry analyzer.
The ACE® Carbamazepine Reagent contains two reagents, an Antibody/Substrate reagent and an Enzyme Conjugate reagent. The assay uses specific antibodies to carbamazepine and is based on the competition of an enzyme glucose-6-phosphate dehydrogenase (G6PDH) labeled drug and the free drug from the sample, for a fixed amount of specific antibody binding sites . In the absence of free drug from the sample, the drug-labeled G6PDH is bound by the specific antibody and the enzyme activity is inhibited. This phenomenon creates a relationship between drug concentration in the sample and the enzyme activity. The enzyme G6PDH activity is determined bichromatically on the ACE® at 340/505 nm by measuring its ability to convert NAD* to NADH.
The ACE® Carbamazepine Reagent is an enzyme immunoassay intended for the quantitative determination of carbamazepine in human serum.
Here's an analysis of the acceptance criteria and the study that proves the device meets them:
1. Table of Acceptance Criteria and Reported Device Performance
| Parameter | Acceptance Criteria (Predicate Device K955100) | Reported Device Performance (ACE® Carbamazepine Reagent) |
|---|---|---|
| Assay Range | 0.5 µg/mL to 20 µg/mL | 0.3 µg/mL to 20 µg/mL |
| Precision | ||
| Within Run |
Ask a specific question about this device
Page 1 of 1